Categories Cancer Treatment

Study: New research may lead to a blood test that detects breast cancer recurrence earlier

Recent headlines announced a blood test that can potentially predict which breast cancer survivors are at risk of recurrence. This particular blood test, one of many being developed, is sometimes called a “liquid biopsy.” This early research focuses on a technique that is promising, but not yet available to breast cancer survivors. (10/12/15)

Note: THIS INFORMATION HAS BEEN UPDATED on 11/07/19 with newly-published data. See our updated article: A new blood test may help predict early-stage breast cancer patients at highest risk for recurrence.

Study: Are more men with breast cancer opting for prophylactic mastectomy?

Recent headlines describe the rise in prophylactic double mastectomy for men with breast cancer. We looked at the research to see how many men are choosing this option and what it means for men with breast cancer. (10/6/15)

Study: All DCIS is not the same: Young women and African American women at higher risk after DCIS diagnosis

Diagnoses of ductal carcinoma in situ (DCIS), sometimes called stage 0 breast cancer, have increased in recent decades. Many people with DCIS wonder if they need aggressive treatment. A study looking at the survival of over 100,000 women found that breast cancer mortality after DCIS is low (3%), and identified groups of women who are at higher risk after DCIS. (9/8/15)